Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Absci Corp (ABSI)

Absci Corp (ABSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference

ABSI : 2.61 (-2.61%)
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care

/CNW/ -- Healthcare is undergoing a transformative shift, with new technologies enabling breakthroughs that were once unimaginable. According to the World...

AVAI : 0.5200 (+4.00%)
TWST : 40.55 (-1.36%)
SYK : 386.46 (+0.20%)
ABSI : 2.61 (-2.61%)
RDNT : 82.13 (-0.04%)
Inside the AI-Healthcare Boom: Breakthroughs in Diagnostics and Personalized Treatment

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – A recent World Economic Forum report highlights AI's potential to ease the strain on healthcare systems...

MSFT : 415.47 (+0.20%)
NVDA : 146.89 (+0.69%)
TWST : 40.55 (-1.36%)
AVAI : 0.5200 (+4.00%)
ABSI : 2.61 (-2.61%)
RXRX : 5.89 (-2.48%)
EXAI : 4.84 (+3.20%)
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

ABSI : 2.61 (-2.61%)
Absci to Host R&D Day on December 12, 2024

ABSI : 2.61 (-2.61%)
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI

ABSI : 2.61 (-2.61%)
Absci to Participate in Upcoming Investor Conferences

ABSI : 2.61 (-2.61%)
Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

ABSI : 2.61 (-2.61%)
1 'Strong Buy' Penny Stock to Invest in AI Drug Development

Investors seeking AI-led drug development opportunities can consider this top-rated biotech stock under $5.

AZN : 63.69 (+0.78%)
ABSI : 2.61 (-2.61%)
AI and Biotech Developers Lead the Charge in the Next Healthcare Transformation

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Earlier this year, US President Joe Biden and his administration put out a new executive order on safe, secure, and...

AVAI : 0.5200 (+4.00%)
MYO : 4.92 (-0.20%)
PRCT : 93.61 (+0.98%)
ISRG : 542.58 (+0.14%)
ABSI : 2.61 (-2.61%)

Barchart Exclusives

Is Palo Alto Networks Stock a Buy or Sell?
Palo Alto delivered better-than-expected revenue and profitability in Q1, and the cybersecurity giant even raised its full-year guidance. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar